Details for New Drug Application (NDA): 018202

✉ Email this page to a colleague

NDA 018202 describes CYTADREN, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the CYTADREN profile page.

The generic ingredient in CYTADREN is aminoglutethimide. Additional details are available on the aminoglutethimide profile page.

Summary for 018202

Tradename:	CYTADREN
Applicant:	Novartis
Ingredient:	aminoglutethimide
Patents:	0

Medical Subject Heading (MeSH) Categories for 018202

Antineoplastic Agents, Hormonal
Aromatase Inhibitors

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	250MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	No

Expired US Patents for NDA 018202

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	CYTADREN	aminoglutethimide	TABLET;ORAL	018202-001	Approved Prior to Jan 1, 1982	3,595,960	⤷ Subscribe
Novartis	CYTADREN	aminoglutethimide	TABLET;ORAL	018202-001	Approved Prior to Jan 1, 1982	3,944,671	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.